Celator Pharmaceuticals' P2P Acquisition

Celator Pharmaceuticals raised a round of funding on July 13, 2016. Investors include Jazz Pharmaceuticals.

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identif…

Articles about Celator Pharmaceuticals' P2P Acquisition: